Oropharyngeal Squamous Cell Carcinoma Recurrent
1 clinical trials · Condition
◉ Watch Oropharyngeal Squamous Cell Carcinoma Recurrent
| Record | Firm | Date |
|---|---|---|
| A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer (NCT06513884) | Hookipa Biotech GmbH | 2024-12-01 |
Track Oropharyngeal Squamous Cell Carcinoma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.